CUTANEOUS T-CELL LYMPHOMA STAGE III

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE III:

# Drug Count
0 DUPILUMAB 14
1 METHOTREXATE SODIUM 7
2 METHOTREXATE 6
3 AZATHIOPRINE 5
4 CYCLOSPORINE 4
5 ACITRETIN 3
6 ADALIMUMAB 3
7 ADALIMUMAB-AATY 3
8 ADALIMUMAB-ADAZ 3
9 ADALIMUMAB-FKJP 3
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA STAGE III

CUTANEOUS T-CELL LYMPHOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIMECROLIMUS 2 0.0011
1 MECHLORETHAMINE HYDROCHLORIDE 2 0.0009
2 ACITRETIN 3 0.0006
3 BARICITINIB 1 0.0003
4 BETAMETHASONE DIPROPIONATE 1 0.0001
5 NAPROXEN SODIUM 220MG 1 0.0001
6 ADALIMUMAB-FKJP 3 0.0001
7 ADALIMUMAB-AATY 3 0.0001
8 AZATHIOPRINE 5 0.0001
9 ADALIMUMAB-ADAZ 3 0.0001
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA STAGE III